Project Profile

Open-label Phase 1/2 (Safety Lead-in) Study of Trans Sodiumwith Concomitant Treatment of Fractionated Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Patients to Evaluate Safety and Efficacy

Keyword Search